Strides Pharma Science Limited

FDA Regulatory Profile

Strides Pharma Science Limited appears in FDA public data with 1 recall, 0 510(k) clearances, 12 FDA inspections, and 1 compliance action on record. Its most recent recall (D-1029-2020, Class III) was initiated on February 17, 2020.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
12
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-1029-2020Class IIIPotassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, ManufacFebruary 17, 2020